A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol

BACKGROUND: Cardiovascular complications are the leading cause of mortality and morbidity in Marfan syndrome (MFS), a dominantly inherited disorder caused by mutations in the gene that encodes fibrillin-1. There are approximately 18,000 patients in the UK with MFS. Current treatment includes careful...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Trials
Main Authors: Mullen, Michael J, Flather, Marcus D, Jin, Xu Yu, Newman, William G, Erdem, Guliz, Gaze, David, Valencia, Oswaldo, Banya, Winston, Foley, Claire E, Child, Anne
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2013
נושאים:
Study Protocol
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4220813/
https://ncbi.nlm.nih.gov/pubmed/24289736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-14-408
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים